P5320Trimethylamine-N-oxide (TMAO) Predicts Total Mortality, but not Recurrent Venous Thromboembolism in Elderly Patients with Acute Venous Thromboembolism

Martin F. Reiner(University of Zurich), Jürg H. Beer(University of Zurich), Nicole R. Bonetti(University Hospital Zurich), Andreas Limacher(University of Bern), Simona Stivala(University of Basel), Deborah Mueller(University Hospital Zurich), Marie Méan(University of Lausanne), S Gobbato(University of Zurich), Arnold von Eckardstein(University Hospital of Zurich), Drahomir Aujesky(General Department of Preventive Medicine), Nicolas Rodondi(General Department of Preventive Medicine), Odile Stalder(University of Bern), Giovanni G. Camici(University of Zurich), T.F. Luescher(Zurich Heart House)
European Heart Journal
August 1, 2017
10.1093/eurheartj/ehx493.p5320
Cited by 0

Related Papers

Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement
|European Heart Journal|2022|1.3k
Subclinical Hypothyroidism and the Risk of Coronary Heart Disease and Mortality
|JAMA|2010|1.2k
Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points—a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine
|European Heart Journal|2016|830
Impact of Oxidative Stress on the Heart and Vasculature
|Journal of the American College of Cardiology|2017|603
Thyroid Function Within the Normal Range, Subclinical Hypothyroidism, and the Risk of Atrial Fibrillation
|Circulation|2017|247